DOSSIER · 13F Holders · Q3 2026
BIOCRYST PHARMACEUTICALS INC
5 institutions still hold BIOCRYST PHARMACEUTICALS INC as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 09058V953·5 13F holders·last filed Sep 30, 2026
AI Holders Summary · Q3 2026
5 institutions reported BIOCRYST PHARMACEUTICALS INC in Q3 2026. JPMORGAN CHASE & CO leads at 36.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.